Which DMARD for ICI-associated arthritis?

被引：0
|
作者：
Onuora, Sarah
机构：
[1] Nature Reviews Rheumatology,
来源：
NATURE REVIEWS RHEUMATOLOGY | 2023年 / 19卷 / 07期
关键词：
D O I：
10.1038/s41584-023-00983-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In a retrospective study, biologic DMARD therapy was associated with faster control of immune checkpoint inhibitor-associated arthritis but also with a shorter time to cancer progression, compared with methotrexate therapy.
引用
收藏
页码：395 / 395
页数：1
相关论文
共 50 条
  • [41] Timing of biological DMARD treatment in juvenile idiopathic arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2021, 3 (08): : E550 - E550
  • [42] DMARD Utilization Pattern in Older Adults with Rheumatoid Arthritis
    Seelmann, Daniela
    Lee, Jiha
    Misra, Devyani
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2793 - 2795
  • [43] Aspects of early arthritis - Traditional DMARD therapy: is it sufficient?
    Machold, Klaus P.
    Nell, Valerie P. K.
    Stamm, Tanja A.
    Smolen, Josef S.
    ARTHRITIS RESEARCH & THERAPY, 2006, 8 (03)
  • [44] Leflunomide is an effective new DMARD for active rheumatoid arthritis
    不详
    Drugs & Therapy Perspectives, 2000, 16 (1) : 1 - 5
  • [45] A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis
    Jobanputra, P
    Wilson, J
    Douglas, K
    Burls, A
    RHEUMATOLOGY, 2004, 43 (02) : 206 - 210
  • [46] Clinical pharmacology of combination DMARD therapy in rheumatoid arthritis
    Furst, DE
    JOURNAL OF RHEUMATOLOGY, 1996, 23 : 86 - 90
  • [47] COMBINATION DMARD THERAPY FOR RHEUMATOID-ARTHRITIS - TOLERABILITY
    ODELL, J
    HAIRE, C
    ERIKSON, N
    DRYMALSKI, W
    PALMER, W
    ECKHOFF, J
    GARWOOD, V
    MALOLEY, P
    ILLERA, V
    KLASSEN, L
    MOORE, G
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S53 - S53
  • [48] HOSPITAL ADMISSIONS OF PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH DMARD
    Cervantes Perez, E. G.
    Maneiro, J. R.
    Souto Vilas, A.
    Mera Varela, J. A.
    Gomez-Rein, J. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1159 - 1159
  • [49] Kutane leukozytoklastische Vaskulitis im Rahmen einer rheumatoiden Arthritis unter DMARD TherapieCutaneous leukocytoclastic vasculitis in a patient with rheumatoid arthritis on DMARD therapy
    K. Stolz-Kasinger
    T. Nothnagl
    B. Rintelen
    rheuma plus, 2017, 16 (2) : 64 - 66
  • [50] FACTORS WHICH CONTRIBUTE TO FATIGUE ASSOCIATED WITH RHEUMATOID-ARTHRITIS
    CROSBY, LJ
    JOURNAL OF ADVANCED NURSING, 1991, 16 (08) : 974 - 981
12345